Morningstar: DraftKings Trading Well Below Fair Value Estimate
DraftKings (DKNG) shares are down 40% YTD, but Morningstar analyst Dan Wasiolek argues the stock is undervalued, with a $39 fair value estimate. Despite regulatory uncertainty, Morningstar rates it five stars, forecasting 8.1% sales and 24.9% EBITDA growth from 2026-2035. The NBA's crackdown on player proposition markets is not expected to hinder sports betting demand.
How this was made
The 30-second read
Why it matters
The rating and fair‑value estimate provide a fresh, actionable thesis for traders.
Market read
Analyst upgrade could trigger buying interest and lift DraftKings and related sportsbook stocks.
What to watch
Potential capital allocation to prediction‑market ventures may dampen near‑term earnings.
Background
Morningstar analyst Dan Wasiolek highlights DraftKings' strong core business despite spending on prediction‑market platforms and notes NBA market restrictions will not curb demand.
Ticker impact
Morningstar rates DraftKings five stars with a $39 fair value, implying significant upside from current $20.50 price.
likely upward pressure as investors price in the undervaluation thesis
Morningstar's high rating and explicit fair‑value target provide a concrete catalyst for buying interest.
Market effects
May lift sentiment across the broader sports‑betting and online gaming sector.
U.S. market focus as DraftKings is a Nasdaq‑listed peer.
Limited to U.S. equities; no direct global macro effect.
Counterpoint
If regulatory uncertainty persists, the fair‑value upside could be overstated.
Key entities
- companyDraftKings
U.S. online sports‑betting and gaming operator (NASDAQ: DKNG).
- analyst_firmMorningstar
Research firm issuing the five‑star rating and $39 fair‑value estimate.
